Validation Consultant and Process Development of Clinical Drugs
Consultant #714
Expertise
- Identify, evaluate & recommend contract manufacturers for clinical & commercial scale drug substance (API) & dosage forms for topical, solution, solid dosage, and injectable projects.
- Manage ongoing outsourced manufacturing activities for API and drug product for 4 virtual pharmaceutical companies.
- Draft & negotiate supply and quality agreements with GMP contract manufacturers.
- Review and edit CMC sections of IND Annual Report filings for a new peptide drug product. Provide technical, regulatory and QA guidance to the virtual company developing this product.
- Prepare detailed Scope of Work document for a process development project being outsourced by a major generics company.
- Represent pharmaceutical clients at project meetings, FDA meetings, and on-site during manufacturing campaigns. Prepare FDA briefing documents for pre-IND and EP2 meetings.
- Review and edit development report, batch records, and technology transfer protocols for sterile pharmaceutical product.
- Prepare and review validation master plan and process validation protocols for commercial scale active pharmaceutical ingredient synthesis.
- Audit contract manufacturing facilities to assess cGMP compliance.
- Project planning for a new biotech company's first IND filing.
- Write, review, and/or revise SOPs, analytical methods, and project specifications for raw materials, drug substance, and drug product, and to establish a quality assurance system.
- Draft and edit CMC sections for IND and NDA filings and assist contract manufacturer in DMF preparation.
- Perform due diligence investigations for potential product and technology acquisitions by client biotech companies, including peptide and protein products and medical devices.
- Developed strategic plan for in-house and outsourced development activities directed toward IND filing & clinical studies on two new chemical entity therapeutics.
- Cost analysis assessment of commercial viability of potential drug substances.
- Staffed & equipped in-house analytical development and peptide synthesis groups.
- Identified & evaluated outside supplier for scale-up & production of bulk peptides under cGMP, formulation development, and clinical dosage form manufacturing.
Experience
CDR Therapeutics, Seattle Washington, Director, Chemical Dev.; Acting Director, Medicinal Chemistry
Responsible for establishing the chemical development and drug discovery functions at a new biopharmaceutical company, with the goal of developing peptide and/or small molecules as therapeutics based on the CDR regions of antibodies.
- Developed strategic plan for a combination of in-house and outsourced development activities directed toward IND filing & clinical studies on two new chemical entity therapeutics
- Cost analysis assessment of commercial viability of potential drug substances
- Staffed and equipped in-house analytical development and peptide synthesis group
- Identified & evaluated outside suppliers for scale-up & production of bulk peptides under cGMP
- Formulation development, and clinical dosage form manufacturing
- Designed and cost-effectively equipped a chemistry laboratory for a new facility
- Developed HPLC methods for evaluation of purity & stability of 4 lead compounds and for identification of major degradation products
ProCyte Corporation, Kirkland, WA, Director, Chemical Development; Manger, Process Development
Responsible for leadership of chemical development group in process development, analytical methods department, clinical manufacturing for drug substances, formulated drug products & medical devices, and validation activities
- Development & transfer to manufacturing of a process for synthesis of a tripeptide copper complex as a BPC and device component. Reduced cost of goods by >95% from the cost of purchased material by utilization of an unconventional synthetic route & less costly starting materials
- Development, scale up, clinical & commercial production of derivatized polymers as wound care device components - 7 months from acquisition of core technology to production of first commercial materials, utilizing a staff initially unfamiliar with polymer chemistry
- Led project team responsible for initiating commercial manufacturing of OsmoCyte R line of polymer-based wound care devices, including raw material sourcing, process, specification & method development, primary manufacturing equipment design, packaging, cost analysis and production planning
- Led troubleshooting teams for investigation of raw material or product failures, and for providing continued cost reductions through process improvements
Berlex Laboratories, Cedar Knolls, NJ, Scientist, Biophysical Chemistry; Scientist, Peptide Chemistry
- Solid phase and multi-gram solution syntheses of peptides and cyclic peptide analogues as potential enzyme inhibitors and receptor antagonists
- Combined techniques of solid phase and solution chemistry to synthesize defined-size oligomers of polycationic lipid-lowering agents for calibration of size-exclusion HPLC method
Immunobiology Research Institute, Senior Research Scientist, Peptide Development
Ortho Pharmaceutical, Senior Research Scientist, Peptide Development , Research Scientist, Peptide Development
McNeil Pharmaceutical, Postdoctoral Fellow, Medicinal Chemistry
Honors & Publications
PROFESSIONAL ASSOCIATIONS
- American Chemical Society
- American Peptide Society
- International Society of Pharmaceutical Engineers - Invited Speaker
- International Association of Pharmaceutical Science & Technology
- Drug Information Association
- Washington State Biotechnology Association
- Telementoring Young Women in Science
PUBLICATIONS
- Seven in leading scientific journals
Education
EDUCATION
- Ph.D., Organic Chemistry, Michigan State University
- B. S., Chemistry, Michigan State University
CONTINUING EDUCATION
- GMP Manufacturer of Bulk Drug Substance
- Bulk Active Pharmaceuticals - A Current Regulatory Perspective
- Outsourcing Pharmaceutical Manufacturing
- Process Validation
- Design & Validation of Pharmaceutical Facilities
- Compliance Auditing for Pharmaceutical Manufacturing
- HPLC Methods Development
- Practical Hydrogenation Technology
- Quality & GMP Auditing
- Lyophilization, Freeze Drying Technology
- Financial Accounting for Non-financial Managers
- Management Techniques for Scientists
- American Peptide Symposium
